AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimital-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Talent India

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimital-M 1 Tablet PR

DiabetaComb 1 tablet is an antidiabetic medication, a dual-action formulation for adult-onset type 2 diabetes. It regulates blood glucose levels. Administer DiabetaComb 1 tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking DiabetaComb 1 tablet as prescribed, even if feeling well or experiencing controlled blood sugar; abrupt cessation can elevate blood glucose, risking complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to identify symptoms (sweating, dizziness, headache, tremors) and manage them promptly. Maintain regular meals and carry a quick-acting glucose source (e.g., sugary foods, juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any prior heart conditions before starting treatment; it may be unsuitable. Pregnant or breastfeeding individuals must consult their physician. Regular blood glucose monitoring and blood tests (cell counts, liver function) are recommended.

Uses of Glimital-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimital-M 1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer one Glimital-M tablet post-prandially.

Common Side effects of Glimital-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimital-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer one Glimital-M PR tablet with a meal.

How Glimital-M 1 Tablet PR works:

Glimepiride/Metformin (Glimital-M 1 Tablet PR) combines two distinct antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimital-M 1 Tablet PR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimital-M 1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimital-M 1 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glimital-M 1 Tablet PR, potentially requiring a modified dosage. Consult your physician for guidance. Glimital-M 1 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, the use of Glimital-M 1 Tablet PR requires careful monitoring. Dosage modification of Glimital-M 1 Tablet PR might be necessary. Physician consultation is advised. In those with mild to moderate liver disease, Glimital-M 1 Tablet PR is typically initiated at a reduced dosage; however, it's contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glimital-M 1 Tablet PR :

Should you forget to take your Glimital-M 1 Tablet PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimital-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimital-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimital-M 1 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare but harmful side effect is more likely in patients with kidney disease, older individuals, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glimital-M 1 Tablet PR and seek immediate medical attention.
Glimital-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimital-M 1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimital-M 1 Tablet PR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimital-M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimital-M 1 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Glimital-M 1 Tablet PR
86
MRP 99
13% off